1993
DOI: 10.1016/0735-1097(93)90409-t
|View full text |Cite
|
Sign up to set email alerts
|

Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis

Abstract: This analysis supports the hypotheses that 1) mural thrombus after myocardial infarction poses a significantly increased risk of embolization, 2) the risk of embolization is reduced by systemic anticoagulation, and 3) anticoagulation can prevent mural thrombus formation. Thrombolytic therapy may prevent mural thrombus formation, but evidence for a similar benefit of antiplatelet therapy is lacking.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

7
220
1
8

Year Published

1999
1999
2021
2021

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 366 publications
(244 citation statements)
references
References 43 publications
7
220
1
8
Order By: Relevance
“…Although no randomized control trial data exist, in a meta-analysis that included 270 patients with anterior myocardial infarction and documented LV thrombus, anticoagulation (compared to no anticoagulation) was associated with an 86 percent reduction in the rate of embolization. 21 Based on these findings, the 2012 American College of Chest Physicians Guidelines on Antithrombotic Therapy and Prevention of Thrombosis Guidelines recommends the use of warfarin for at least 3 months with a goal international normalized ratio of 2.0e3.0, followed by patientselective decisions to continue antico-agulation. 22 In conclusion, this case of unrecognized myocardial infarction in the setting of blunt chest trauma highlights the importance of careful consideration of cardiac injury in the emergency setting.…”
Section: What Might Lead To a Missed Diagnosis Of This Condition?mentioning
confidence: 99%
“…Although no randomized control trial data exist, in a meta-analysis that included 270 patients with anterior myocardial infarction and documented LV thrombus, anticoagulation (compared to no anticoagulation) was associated with an 86 percent reduction in the rate of embolization. 21 Based on these findings, the 2012 American College of Chest Physicians Guidelines on Antithrombotic Therapy and Prevention of Thrombosis Guidelines recommends the use of warfarin for at least 3 months with a goal international normalized ratio of 2.0e3.0, followed by patientselective decisions to continue antico-agulation. 22 In conclusion, this case of unrecognized myocardial infarction in the setting of blunt chest trauma highlights the importance of careful consideration of cardiac injury in the emergency setting.…”
Section: What Might Lead To a Missed Diagnosis Of This Condition?mentioning
confidence: 99%
“…LV thrombi are clinically important because of their ability to embolize [25,26]. In fact, patients who develop mural thrombi after MI have a poor prognosis, including a 10% rate of systemic embolization [27].…”
Section: Thrombusmentioning
confidence: 99%
“…The cause of MI was spontaneous coronary artery disection, which was managed conservatively without stenting because there was no evidence for ongoing myocardial ischemia, and there is no established benefit from antiplatelet therapy for this indication [1]. Dabigatran was chosen to treat the LV mural thrombus because in the RE-LY trial [2] the risk of intracranial haemorrhage was lower for patients treated with dabigatran compared to warfarin, and the estimated 10-15% thromboembolic risk from the mural thrombus [3] was thought to be greater than the low risk of further intracranial bleeding >1 week after a traumatic SAH [4].…”
Section: Introductionmentioning
confidence: 99%